Breast Cancer Awareness Month
[New Webinar] In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women…
[On-Demand Presentation] Imaging Data Quality
Watch this on-demand presentation about imaging data quality and how the advancements in AI and machine learning help track the quality of images, assess issues…
[Webinar] Getting Ahead of the Expanding Landscape: Radiopharmaceutical Dosimetry
...overall program. We explore the challenges of conducting dosimetry in all phases of trials, offering insights into trial start-up, dosimetry conduct, collection, and implementation…
Artificial Intelligence Can Boost Reliability and Speed of Medical Imaging Analysis in Clinical Trials
...areas, including detection of lesions and infarcts in brain scans, measurement of liver and spleen volume in metabolic disease, with the ability to review…
[Infographic] The Key Role of Imaging in Clinical Trials
This brand new infographic explores the different types of imaging techniques, their advantages, limitations, and how they can be successfully implemented in clinical trials.
What You Missed: The International Liver Conference
The International Liver Congress (ILC) took place digitally this year, but it was worth logging in to keep up-to-date on the novel findings in imaging…
The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals
In a new article, experts from Medpace’s radiation oncology, imaging, regulatory, and operational teams discuss the growing space of radiopharmaceutical development.
Medidata and Medpace Sign Agreement to Integrate Imaging and Clinical Data into a Single Platform
Medpace is excited to announce an agreement with Medidata to integrate imaging and clinical data into a single platform. The MCL-Medidata partnership offers Sponsors seamless…
Medpace Core Laboratories is Pleased to Announce A Successfully Completed Inspection by the FDA
Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…